Shreeram Aradhye - Sep 15, 2021 Form 4 Insider Report for Dicerna Pharmaceuticals Inc (DRNA)

Signature
/s/ Douglas W. Pagan, attorney-in-fact
Stock symbol
DRNA
Transactions as of
Sep 15, 2021
Transactions value $
-$44,142
Form type
4
Date filed
9/17/2021, 06:48 PM
Previous filing
May 24, 2021
Next filing
Dec 17, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction DRNA Common Stock Options Exercise +7.03K 7.03K Sep 15, 2021 Direct F1
transaction DRNA Common Stock Sale -$44.1K -2.06K -29.27% $21.47 4.97K Sep 17, 2021 Direct F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction DRNA Restricted Stock Units Options Exercise $0 -7.03K -25% $0.00 21.1K Sep 15, 2021 Common Stock 7.03K Direct F1, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit ("RSU") represents the contingent right to receive one share of the Issuer's Common Stock.
F2 Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of the RSUs and does not represent a discretionary trade by the Reporting Person.
F3 Represents RSUs that vest over a period of four years, with 25% of the RSUs vesting on each of the first, second, third and fourth anniversaries of September 15, 2020, subject in each case to the Reporting Person's continued employment or service with the Issuer through the applicable vesting date.